Robenacoxib (Italian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Robenacoxib" in Italian language version.

refsWebsite

Global rank Italian rank

14nih.gov

4^th place

9^th place

12oadoi.org

799^th place

22^nd place

12doi.org

2^nd place

7^th place

doi.org

dx.doi.org

JN. King, J. Dawson; RE. Esser; R. Fujimoto; EF. Kimble; W. Maniara; PJ. Marshall; L. O'Byrne; E. Quadros; PL. Toutain; P. Lees, Preclinical pharmacology of robenacoxib: a novel selective inhibitor of cyclooxygenase-2., in J Vet Pharmacol Ther, vol. 32, n. 1, febbraio 2009, pp. 1-17, DOI:10.1111/j.1365-2885.2008.00962.x, PMID 19161451.
VB. Schmid, W. Seewald; P. Lees; JN. King, In vitro and ex vivo inhibition of COX isoforms by robenacoxib in the cat: a comparative study., in J Vet Pharmacol Ther, vol. 33, n. 5, ottobre 2010, pp. 444-52, DOI:10.1111/j.1365-2885.2010.01166.x, PMID 20840388.
JN. King, M. Jung; MP. Maurer; VB. Schmid; W. Seewald; P. Lees, Effects of route of administration and feeding schedule on pharmacokinetics of robenacoxib in cats., in Am J Vet Res, vol. 74, n. 3, marzo 2013, pp. 465-72, DOI:10.2460/ajvr.74.3.465, PMID 23438125.
HE. Silber, C. Burgener; IM. Letellier; M. Peyrou; M. Jung; JN. King; P. Gruet; JM. Giraudel, Population pharmacokinetic analysis of blood and joint synovial fluid concentrations of robenacoxib from healthy dogs and dogs with osteoarthritis., in Pharm Res, vol. 27, n. 12, dicembre 2010, pp. 2633-45, DOI:10.1007/s11095-010-0262-z, PMID 20922466.
M. Jung, P. Lees; W. Seewald; JN. King, Analytical determination and pharmacokinetics of robenacoxib in the dog., in J Vet Pharmacol Ther, vol. 32, n. 1, febbraio 2009, pp. 41-8, DOI:10.1111/j.1365-2885.2008.01035.x, PMID 19161454.
VB. Schmid, DE. Spreng; W. Seewald; M. Jung; P. Lees; JN. King, Analgesic and anti-inflammatory actions of robenacoxib in acute joint inflammation in dog., in J Vet Pharmacol Ther, vol. 33, n. 2, aprile 2010, pp. 118-31, DOI:10.1111/j.1365-2885.2009.01117.x, PMID 20444036.
N. Reymond, C. Speranza; P. Gruet; W. Seewald; JN. King, Robenacoxib vs. carprofen for the treatment of canine osteoarthritis; a randomized, noninferiority clinical trial., in J Vet Pharmacol Ther, vol. 35, n. 2, aprile 2012, pp. 175-83, DOI:10.1111/j.1365-2885.2011.01297.x, PMID 21480932.
D. Bennett, PD. Eckersall; M. Waterston; V. Marchetti; A. Rota; E. McCulloch; S. Sbrana, The effect of robenacoxib on the concentration of C-reactive protein in synovial fluid from dogs with osteoarthritis., in BMC Vet Res, vol. 9, 2013, p. 42, DOI:10.1186/1746-6148-9-42, PMID 23452411.
P. Gruet, W. Seewald; JN. King, Evaluation of subcutaneous and oral administration of robenacoxib and meloxicam for the treatment of acute pain and inflammation associated with orthopedic surgery in dogs., in Am J Vet Res, vol. 72, n. 2, febbraio 2011, pp. 184-93, DOI:10.2460/ajvr.72.2.184, PMID 21281192.
JM. Giraudel, P. Gruet; DG. Alexander; W. Seewald; JN. King, Evaluation of orally administered robenacoxib versus ketoprofen for treatment of acute pain and inflammation associated with musculoskeletal disorders in cats., in Am J Vet Res, vol. 71, n. 7, luglio 2010, pp. 710-9, DOI:10.2460/ajvr.71.7.710, PMID 20594071.
JN. King, R. Hotz; EL. Reagan; DR. Roth; W. Seewald; P. Lees, Safety of oral robenacoxib in the cat., in J Vet Pharmacol Ther, vol. 35, n. 3, giugno 2012, pp. 290-300, DOI:10.1111/j.1365-2885.2011.01320.x, PMID 21736587.
M. Kamata, JN. King; W. Seewald; N. Sakakibara; K. Yamashita; R. Nishimura, Comparison of injectable robenacoxib versus meloxicam for peri-operative use in cats: results of a randomised clinical trial., in Vet J, vol. 193, n. 1, luglio 2012, pp. 114-8, DOI:10.1016/j.tvjl.2011.11.026, PMID 22227226.

nih.gov

ncbi.nlm.nih.gov

JN. King, J. Dawson; RE. Esser; R. Fujimoto; EF. Kimble; W. Maniara; PJ. Marshall; L. O'Byrne; E. Quadros; PL. Toutain; P. Lees, Preclinical pharmacology of robenacoxib: a novel selective inhibitor of cyclooxygenase-2., in J Vet Pharmacol Ther, vol. 32, n. 1, febbraio 2009, pp. 1-17, DOI:10.1111/j.1365-2885.2008.00962.x, PMID 19161451.
IU. Emmerich, [New drugs for small animals in 2009]., in Tierarztl Prax Ausg K Kleintiere Heimtiere, vol. 38, n. 5, 2010, pp. 300-12, PMID 22215315.
VB. Schmid, W. Seewald; P. Lees; JN. King, In vitro and ex vivo inhibition of COX isoforms by robenacoxib in the cat: a comparative study., in J Vet Pharmacol Ther, vol. 33, n. 5, ottobre 2010, pp. 444-52, DOI:10.1111/j.1365-2885.2010.01166.x, PMID 20840388.
JN. King, M. Jung; MP. Maurer; VB. Schmid; W. Seewald; P. Lees, Effects of route of administration and feeding schedule on pharmacokinetics of robenacoxib in cats., in Am J Vet Res, vol. 74, n. 3, marzo 2013, pp. 465-72, DOI:10.2460/ajvr.74.3.465, PMID 23438125.
HE. Silber, C. Burgener; IM. Letellier; M. Peyrou; M. Jung; JN. King; P. Gruet; JM. Giraudel, Population pharmacokinetic analysis of blood and joint synovial fluid concentrations of robenacoxib from healthy dogs and dogs with osteoarthritis., in Pharm Res, vol. 27, n. 12, dicembre 2010, pp. 2633-45, DOI:10.1007/s11095-010-0262-z, PMID 20922466.
M. Jung, P. Lees; W. Seewald; JN. King, Analytical determination and pharmacokinetics of robenacoxib in the dog., in J Vet Pharmacol Ther, vol. 32, n. 1, febbraio 2009, pp. 41-8, DOI:10.1111/j.1365-2885.2008.01035.x, PMID 19161454.
VB. Schmid, DE. Spreng; W. Seewald; M. Jung; P. Lees; JN. King, Analgesic and anti-inflammatory actions of robenacoxib in acute joint inflammation in dog., in J Vet Pharmacol Ther, vol. 33, n. 2, aprile 2010, pp. 118-31, DOI:10.1111/j.1365-2885.2009.01117.x, PMID 20444036.
N. Reymond, C. Speranza; P. Gruet; W. Seewald; JN. King, Robenacoxib vs. carprofen for the treatment of canine osteoarthritis; a randomized, noninferiority clinical trial., in J Vet Pharmacol Ther, vol. 35, n. 2, aprile 2012, pp. 175-83, DOI:10.1111/j.1365-2885.2011.01297.x, PMID 21480932.
K. Edamura, JN. King; W. Seewald; N. Sakakibara; M. Okumura, Comparison of oral robenacoxib and carprofen for the treatment of osteoarthritis in dogs: a randomized clinical trial., in J Vet Med Sci, vol. 74, n. 9, settembre 2012, pp. 1121-31, PMID 22673598.
D. Bennett, PD. Eckersall; M. Waterston; V. Marchetti; A. Rota; E. McCulloch; S. Sbrana, The effect of robenacoxib on the concentration of C-reactive protein in synovial fluid from dogs with osteoarthritis., in BMC Vet Res, vol. 9, 2013, p. 42, DOI:10.1186/1746-6148-9-42, PMID 23452411.
P. Gruet, W. Seewald; JN. King, Evaluation of subcutaneous and oral administration of robenacoxib and meloxicam for the treatment of acute pain and inflammation associated with orthopedic surgery in dogs., in Am J Vet Res, vol. 72, n. 2, febbraio 2011, pp. 184-93, DOI:10.2460/ajvr.72.2.184, PMID 21281192.
JM. Giraudel, P. Gruet; DG. Alexander; W. Seewald; JN. King, Evaluation of orally administered robenacoxib versus ketoprofen for treatment of acute pain and inflammation associated with musculoskeletal disorders in cats., in Am J Vet Res, vol. 71, n. 7, luglio 2010, pp. 710-9, DOI:10.2460/ajvr.71.7.710, PMID 20594071.
JN. King, R. Hotz; EL. Reagan; DR. Roth; W. Seewald; P. Lees, Safety of oral robenacoxib in the cat., in J Vet Pharmacol Ther, vol. 35, n. 3, giugno 2012, pp. 290-300, DOI:10.1111/j.1365-2885.2011.01320.x, PMID 21736587.
M. Kamata, JN. King; W. Seewald; N. Sakakibara; K. Yamashita; R. Nishimura, Comparison of injectable robenacoxib versus meloxicam for peri-operative use in cats: results of a randomised clinical trial., in Vet J, vol. 193, n. 1, luglio 2012, pp. 114-8, DOI:10.1016/j.tvjl.2011.11.026, PMID 22227226.

oadoi.org

JN. King, J. Dawson; RE. Esser; R. Fujimoto; EF. Kimble; W. Maniara; PJ. Marshall; L. O'Byrne; E. Quadros; PL. Toutain; P. Lees, Preclinical pharmacology of robenacoxib: a novel selective inhibitor of cyclooxygenase-2., in J Vet Pharmacol Ther, vol. 32, n. 1, febbraio 2009, pp. 1-17, DOI:10.1111/j.1365-2885.2008.00962.x, PMID 19161451.
VB. Schmid, W. Seewald; P. Lees; JN. King, In vitro and ex vivo inhibition of COX isoforms by robenacoxib in the cat: a comparative study., in J Vet Pharmacol Ther, vol. 33, n. 5, ottobre 2010, pp. 444-52, DOI:10.1111/j.1365-2885.2010.01166.x, PMID 20840388.
JN. King, M. Jung; MP. Maurer; VB. Schmid; W. Seewald; P. Lees, Effects of route of administration and feeding schedule on pharmacokinetics of robenacoxib in cats., in Am J Vet Res, vol. 74, n. 3, marzo 2013, pp. 465-72, DOI:10.2460/ajvr.74.3.465, PMID 23438125.
HE. Silber, C. Burgener; IM. Letellier; M. Peyrou; M. Jung; JN. King; P. Gruet; JM. Giraudel, Population pharmacokinetic analysis of blood and joint synovial fluid concentrations of robenacoxib from healthy dogs and dogs with osteoarthritis., in Pharm Res, vol. 27, n. 12, dicembre 2010, pp. 2633-45, DOI:10.1007/s11095-010-0262-z, PMID 20922466.
M. Jung, P. Lees; W. Seewald; JN. King, Analytical determination and pharmacokinetics of robenacoxib in the dog., in J Vet Pharmacol Ther, vol. 32, n. 1, febbraio 2009, pp. 41-8, DOI:10.1111/j.1365-2885.2008.01035.x, PMID 19161454.
VB. Schmid, DE. Spreng; W. Seewald; M. Jung; P. Lees; JN. King, Analgesic and anti-inflammatory actions of robenacoxib in acute joint inflammation in dog., in J Vet Pharmacol Ther, vol. 33, n. 2, aprile 2010, pp. 118-31, DOI:10.1111/j.1365-2885.2009.01117.x, PMID 20444036.
N. Reymond, C. Speranza; P. Gruet; W. Seewald; JN. King, Robenacoxib vs. carprofen for the treatment of canine osteoarthritis; a randomized, noninferiority clinical trial., in J Vet Pharmacol Ther, vol. 35, n. 2, aprile 2012, pp. 175-83, DOI:10.1111/j.1365-2885.2011.01297.x, PMID 21480932.
D. Bennett, PD. Eckersall; M. Waterston; V. Marchetti; A. Rota; E. McCulloch; S. Sbrana, The effect of robenacoxib on the concentration of C-reactive protein in synovial fluid from dogs with osteoarthritis., in BMC Vet Res, vol. 9, 2013, p. 42, DOI:10.1186/1746-6148-9-42, PMID 23452411.
P. Gruet, W. Seewald; JN. King, Evaluation of subcutaneous and oral administration of robenacoxib and meloxicam for the treatment of acute pain and inflammation associated with orthopedic surgery in dogs., in Am J Vet Res, vol. 72, n. 2, febbraio 2011, pp. 184-93, DOI:10.2460/ajvr.72.2.184, PMID 21281192.
JM. Giraudel, P. Gruet; DG. Alexander; W. Seewald; JN. King, Evaluation of orally administered robenacoxib versus ketoprofen for treatment of acute pain and inflammation associated with musculoskeletal disorders in cats., in Am J Vet Res, vol. 71, n. 7, luglio 2010, pp. 710-9, DOI:10.2460/ajvr.71.7.710, PMID 20594071.
JN. King, R. Hotz; EL. Reagan; DR. Roth; W. Seewald; P. Lees, Safety of oral robenacoxib in the cat., in J Vet Pharmacol Ther, vol. 35, n. 3, giugno 2012, pp. 290-300, DOI:10.1111/j.1365-2885.2011.01320.x, PMID 21736587.
M. Kamata, JN. King; W. Seewald; N. Sakakibara; K. Yamashita; R. Nishimura, Comparison of injectable robenacoxib versus meloxicam for peri-operative use in cats: results of a randomised clinical trial., in Vet J, vol. 193, n. 1, luglio 2012, pp. 114-8, DOI:10.1016/j.tvjl.2011.11.026, PMID 22227226.